1. Home
  2. ZSTK vs QNCX Comparison

ZSTK vs QNCX Comparison

Compare ZSTK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZeroStack Corp. Common Stock

ZSTK

ZeroStack Corp. Common Stock

N/A

Current Price

$4.84

Market Cap

19.0M

Sector

Health Care

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$29.55

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZSTK
QNCX
Founded
2019
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
17.5M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
ZSTK
QNCX
Price
$4.84
$29.55
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
17.2K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,676,000.00
N/A
Revenue This Year
$15.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.08
52 Week High
$12.40
$35.41

Technical Indicators

Market Signals
Indicator
ZSTK
QNCX
Relative Strength Index (RSI) 58.54 46.63
Support Level $4.76 $0.82
Resistance Level $5.39 $35.38
Average True Range (ATR) 0.98 2.07
MACD -0.13 -1.04
Stochastic Oscillator 32.52 4.41

Price Performance

Historical Comparison
ZSTK
QNCX

About ZSTK ZeroStack Corp. Common Stock

ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: